U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1997
172
Substance Class
Concept
Record UNII
4F4X42SYQ6
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
RITUXIMAB
EMA EPAR   HSDB   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
RITUXAN
Brand Name English
RITUXIMAB COMPONENT OF RITUXAN HYCELA
Brand Name English
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Common Name English
MAB CHIMERIC (IGG1) ANTI P11836 (CD20_HUMAN) (IDECC2B8)
Common Name English
RITUXIMAB (GENETICAL RECOMBINATION)
JAN  
Official Name English
RITUXIMAB [HSDB]
Common Name English
RITUXIMAB [WHO-DD]
Common Name English
RITUXIMAB [MART.]
Common Name English
RITUXIMAB [MI]
Common Name English
GP2013
Common Name English
RITUXAN HYCELA COMPONENT RITUXIMAB
Brand Name English
MABTHERA
Brand Name English
IDEC-C2B8
Code English
RITUXIMAB [USAN]
Common Name English
RITUXIMAB [EMA EPAR]
Common Name English
USP MAB 001, MONOCLONAL IGG1 [USP-RS]
Common Name English
IDEC-102
Code English
RITUXIMAB [VANDF]
Common Name English
RITUXIMAB [INN]
Common Name English
RITUXIMAB [JAN]
Common Name English
RITUXIMAB [PURPLE BOOK, CDER]
Common Name English
RG-105
Code English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS MABTHERA (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
EMA ASSESSMENT REPORTS MABTHERA (AUTHORIZED: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL)
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
FDA ORPHAN DRUG 177603
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
NDF-RT N0000175078
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
FDA ORPHAN DRUG 781520
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
FDA ORPHAN DRUG 465014
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
FDA ORPHAN DRUG 542416
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
WHO-VATC QL01XC02
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
NCI_THESAURUS C129822
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
EMA ASSESSMENT REPORTS MABTHERA (AUTHORIZED: LYMPHOMA, NON-HODGKIN)
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
FDA ORPHAN DRUG 79793
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
FDA ORPHAN DRUG 546516
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
LIVERTOX 854
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
FDA ORPHAN DRUG 216305
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
NCI_THESAURUS C141215
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
NDF-RT N0000175657
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
FDA ORPHAN DRUG 155102
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
FDA ORPHAN DRUG 545616
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
WHO-ATC L01XC02
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
FDA ORPHAN DRUG 529816
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
EU-Orphan Drug EU/3/17/1869
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
Code System Code Type Description
IUPHAR
6780
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
MERCK INDEX
M9637
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY Merck Index
DRUG BANK
DB00073
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
RXCUI
2273510
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
ALTERNATIVE
USP_CATALOG
1445539
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY USP-RS
JAPANESE REVIEW
RITUXAN
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY APPROVED AUGUST 2014
ChEMBL
CHEMBL1201576
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
WIKIPEDIA
RITUXIMAB
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
NCI_THESAURUS
C1702
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
INN
7609
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
CAS
174722-31-7
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
RXCUI
121191
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY RxNorm
EVMPD
SUB12570MIG
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
MESH
C092560
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
LACTMED
Rituximab
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
EPA CompTox
174722-31-7
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
FDA UNII
4F4X42SYQ6
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
RXCUI
2105824
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
ALTERNATIVE
DRUG CENTRAL
4975
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
JAPANESE REVIEW
ROMIPLATE
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY APPROVED JANUARY 2011
HSDB
7455
Created by admin on Fri Jun 25 21:32:18 UTC 2021 , Edited by admin on Fri Jun 25 21:32:18 UTC 2021
PRIMARY
This is a non-substance concept
Related Record Type Details
B-LYMPHOCYTE ANTIGEN CD20
TARGET->LIGAND
BINDING
RITUXIMAB-ABBS
BIOSIMILAR -> PARENT
RITUXIMAB-ARRX
SUB_CONCEPT->SUBSTANCE
RITUXIMAB-ARRX
BIOSIMILAR -> PARENT
B-LYMPHOCYTE ANTIGEN CD20
TARGET -> INHIBITOR
RITUXIMAB I-131
LABELED -> NON-LABELED
BI-695500
SUB_CONCEPT->SUBSTANCE
HIGH AFFINITY IMMUNOGLOBULIN GAMMA FC RECEPTOR I
TARGET -> SUBSTRATE
HIGH AFFINITY IMMUNOGLOBULIN GAMMA FC RECEPTOR I
TARGET -> AGONIST
RITUXIMAB-ABBS
SUB_CONCEPT->SUBSTANCE
RITUXIMAB-PVVR
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
RITUXIMAB
ACTIVE MOIETY
This is a non-substance concept
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966